Hiroshi Kawachi

7.8k total citations
174 papers, 6.5k citations indexed

About

Hiroshi Kawachi is a scholar working on Nephrology, Molecular Biology and Immunology. According to data from OpenAlex, Hiroshi Kawachi has authored 174 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Nephrology, 77 papers in Molecular Biology and 30 papers in Immunology. Recurrent topics in Hiroshi Kawachi's work include Renal Diseases and Glomerulopathies (111 papers), Chronic Kidney Disease and Diabetes (47 papers) and Ion Transport and Channel Regulation (30 papers). Hiroshi Kawachi is often cited by papers focused on Renal Diseases and Glomerulopathies (111 papers), Chronic Kidney Disease and Diabetes (47 papers) and Ion Transport and Channel Regulation (30 papers). Hiroshi Kawachi collaborates with scholars based in Japan, United States and Germany. Hiroshi Kawachi's co-authors include Fujio Shimizu, Kenji Suzuki, Toshiro Fujita, F Shimizu, Kenichi Watanabe, Hiroko Koike, Yoshiyasu Fukusumi, Tomoko Takano, Lamine Aoudjit and Zemin Cao and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

Hiroshi Kawachi

169 papers receiving 6.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Kawachi Japan 46 3.5k 2.7k 778 768 694 174 6.5k
Maria Pia Rastaldi Italy 43 4.1k 1.2× 2.6k 1.0× 1.4k 1.8× 709 0.9× 759 1.1× 120 7.3k
Chunsun Dai China 52 2.8k 0.8× 4.1k 1.5× 767 1.0× 794 1.0× 1.2k 1.7× 119 8.0k
Xiao Ru Huang Hong Kong 55 2.6k 0.7× 3.9k 1.5× 1.5k 2.0× 365 0.5× 757 1.1× 85 8.3k
Gavin I. Welsh United Kingdom 47 2.0k 0.6× 3.5k 1.3× 493 0.6× 606 0.8× 970 1.4× 141 6.6k
Liliane J. Striker United States 48 2.1k 0.6× 2.2k 0.8× 520 0.7× 933 1.2× 828 1.2× 115 6.9k
Greg H. Tesch Australia 49 2.5k 0.7× 2.3k 0.9× 2.3k 3.0× 497 0.6× 1.1k 1.6× 113 7.9k
Daniela Corna Italy 46 2.3k 0.7× 2.1k 0.8× 789 1.0× 304 0.4× 1.3k 1.8× 105 6.7k
Hans J. Baelde Netherlands 41 1.5k 0.4× 1.8k 0.7× 1.1k 1.4× 698 0.9× 483 0.7× 160 5.8k
Gilbert Moeckel United States 43 1.6k 0.5× 1.9k 0.7× 870 1.1× 561 0.7× 783 1.1× 121 5.4k
Richard J. Coward United Kingdom 31 2.3k 0.6× 1.4k 0.5× 416 0.5× 490 0.6× 619 0.9× 72 4.0k

Countries citing papers authored by Hiroshi Kawachi

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Kawachi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Kawachi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Kawachi more than expected).

Fields of papers citing papers by Hiroshi Kawachi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Kawachi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Kawachi. The network helps show where Hiroshi Kawachi may publish in the future.

Co-authorship network of co-authors of Hiroshi Kawachi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Kawachi. A scholar is included among the top collaborators of Hiroshi Kawachi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Kawachi. Hiroshi Kawachi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fukusumi, Yoshiyasu, et al.. (2025). Cdc42 Activation in Antinephrin Antibody–Induced Nephropathy. Journal of the American Society of Nephrology. 36(11). 2164–2176.
2.
Fukusumi, Yoshiyasu, et al.. (2021). Tacrolimus ameliorates podocyte injury by restoring FK506 binding protein 12 (FKBP12) at actin cytoskeleton. The FASEB Journal. 35(11). e21983–e21983. 17 indexed citations
3.
Kumagai, Takanori, Kenichi Ishizawa, Yutaka Miura, et al.. (2019). Phosphate binding by sucroferric oxyhydroxide ameliorates renal injury in the remnant kidney model. Scientific Reports. 9(1). 1732–1732. 18 indexed citations
4.
Suzuki, Koichi, Yoshiyasu Fukusumi, Hiroshi Kaneko, et al.. (2015). Alteration in the podoplanin–ezrin–cytoskeleton linkage is an important initiation event of the podocyte injury in puromycin aminonucleoside nephropathy, a mimic of minimal change nephrotic syndrome. Cell and Tissue Research. 362(1). 201–213. 20 indexed citations
5.
Maruyama, Takashi, Noboru Fukuda, Tarô Matsumoto, et al.. (2015). Systematic implantation of dedifferentiated fat cells ameliorated monoclonal antibody 1-22-3-induced glomerulonephritis by immunosuppression with increases in TNF-stimulated gene 6. Stem Cell Research & Therapy. 6(1). 80–80. 16 indexed citations
6.
Yamada, Sachiko, Jin Nakamura, Misako Asada, et al.. (2014). Twisted Gastrulation, a BMP Antagonist, Exacerbates Podocyte Injury. PLoS ONE. 9(2). e89135–e89135. 18 indexed citations
7.
Shimizu, Akira, Yukinari Masuda, Arimi Ishikawa, et al.. (2012). Development of lymphatic vasculature and morphological characterization in rat kidney. Clinical and Experimental Nephrology. 16(6). 833–842. 19 indexed citations
8.
Takabatake, Yoshitsugu, Jun‐Ya Kaimori, Tomonori Kimura, et al.. (2010). CD28 superagonist-induced regulatory T cell expansion ameliorates mesangioproliferative glomerulonephritis in rats. Clinical and Experimental Nephrology. 15(1). 50–57. 11 indexed citations
9.
Tanaka, Mari, Misako Asada, Atsuko Y. Higashi, et al.. (2010). Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome. Journal of Clinical Investigation. 120(3). 768–777. 64 indexed citations
10.
Kawachi, Hiroshi, et al.. (2010). Ameliorating Effects of l -Carnitine on Diabetic Podocyte Injury. Journal of Medicinal Food. 13(6). 1324–1330. 5 indexed citations
11.
Hayward, A, Francesca Barone, Robin E. Buckingham, et al.. (2010). Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone Prevents Albuminuria but Not Glomerulosclerosis in Experimental Diabetes. American Journal of Nephrology. 32(5). 393–402. 16 indexed citations
12.
Li, Hongping, Jianxin Zhu, Lamine Aoudjit, et al.. (2006). Rat nephrin modulates cell morphology via the adaptor protein Nck. Biochemical and Biophysical Research Communications. 349(1). 310–316. 38 indexed citations
13.
Mizui, Masayuki, Yoshitaka Isaka, Yasufumi Sato, et al.. (2006). Transcription factor Ets-1 is essential for mesangial matrix remodeling. Kidney International. 70(2). 298–305. 25 indexed citations
14.
Macconi, Daniela, Ariela Benigni, Tiziana Plati, et al.. (2006). Pathophysiologic Implications of Reduced Podocyte Number in a Rat Model of Progressive Glomerular Injury. American Journal Of Pathology. 168(1). 42–54. 126 indexed citations
15.
Suzuki, Koichi, Akira Saito, Tamaki Karasawa, et al.. (2005). Progressive Glomerulonephritis with Increasing Proteinuria Induced by a Second Attack to the Mesangial Cell. 53(4). 117–124.
16.
Suzuki, Koichi, Takeshi Nakatsue, Gi Dong Han, et al.. (2005). Early Intervention in Reducing Dietary Protein Intake Ameliorates Irreversible Mesangioproliferative Glomerulonephritis in Rats. 53(4). 95–107.
17.
Ikezumi, Yohei, Tamaki Karasawa, Gi Dong Han, et al.. (2004). The role of lymphocytes in the experimental progressive glomerulonephritis. Kidney International. 66(3). 1036–1048. 23 indexed citations
18.
Higuchi, Noboru, Hiroki Maruyama, Takeshi Kuroda, et al.. (2003). Hydrodynamics-based delivery of the viral interleukin-10 gene suppresses experimental crescentic glomerulonephritis in Wistar–Kyoto rats. Gene Therapy. 10(16). 1297–1310. 31 indexed citations
19.
Koike, Hiromi, et al.. (2002). IFN-γ誘導可能なタンパク質-10(CXCL10)の、Thy1.1の糸球体腎炎における有足細胞を保護する新規な潜在能力. Journal of the American Society of Nephrology. 13. 346. 1 indexed citations
20.
Ito, Yumi, Hiroko Koike, Yohei Ikezumi, et al.. (2001). Not the ED1^+ but the ED3^+ Macrophage Participates in the Pathogenesis of Irreversible Glomerular Changes. 49(3). 73–80. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Pia Rastaldi Breakdown of academic impact, for papers by Chunsun Dai Breakdown of academic impact, for papers by Xiao Ru Huang Breakdown of academic impact, for papers by Gavin I. Welsh Breakdown of academic impact, for papers by Liliane J. Striker Breakdown of academic impact, for papers by Greg H. Tesch Breakdown of academic impact, for papers by Daniela Corna Breakdown of academic impact, for papers by Hans J. Baelde Breakdown of academic impact, for papers by Gilbert Moeckel Breakdown of academic impact, for papers by Richard J. Coward
Rankless by CCL
2026